Description
Sermorelin 10mg — native GHRH fragment for growth hormone research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
Sermorelin is a synthetic 29-amino acid peptide representing the biologically active 1-29 fragment of human growth hormone-releasing hormone (GHRH). It was the first GHRH analogue approved for clinical use, providing extensive safety and efficacy data.
What the Research Shows
Research has examined Sermorelin’s effects on pituitary GH secretion through GHRH receptor activation. As the native sequence, it produces physiological pulsatile GH release patterns rather than continuous elevation.
Studies investigate its effects on GH and IGF-1 levels, sleep-associated GH secretion, and its use in GH axis assessment. Decades of clinical use provide well-characterised pharmacokinetics and safety profiles.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity. No generic overseas certificates.
→ Full Sermorelin Research Guide
Purity: ≥99% (HPLC)
Form: Lyophilised powder
Molecular Weight: 3357.88 Da
CAS: 86168-78-7
Sequence: GHRH(1-29)-NH₂
Research: PubMed
▸ Australian university verified
▸ ≥99% purity guaranteed
▸ Same-day dispatch from Sydney
▸ Research-grade lyophilised powder
Related Research and Resources
For research use only. Not for human consumption.
